Hims & Hers Health Shareholders Can Join Securities Fraud Class Action

BENSALEM, Pa., Sept. 7, 2026 /CourierPR/ -- Investors in Hims & Hers Health, Inc. (HIMS) have an opportunity to join a securities fraud class action lawsuit, according to the Law Offices of Howard G. Smith. The lawsuit alleges that HIMS engaged in misleading practices and failed to disclose material information about its business operations and prospects.

The complaint, filed between August 4, 2025, and July 29, 2026, asserts that HIMS made false and misleading statements to investors. Specifically, the allegations suggest that the company:

1. Shared consumers' health information with third-party advertising platforms. 2. Charged consumers for prescriptions almost immediately after they submitted an intake form, despite assuring them that a medical provider would find the right treatment for them. 3. Subjected itself to regulatory scrutiny due to the aforementioned practices. 4. Was likely to incur fees and penalties as a result of the practices. 5. Made positive statements about its business, operations, and prospects that were misleading or lacked a reasonable basis.

The lawsuit claims that HIMS's actions have caused substantial losses for its shareholders. Investors who believe they have lost money due to these practices are encouraged to contact the Law Offices of Howard G. Smith before November 2, 2026, to participate in the ongoing securities fraud lawsuit.

The complaint argues that Hims & Hers Health, Inc. failed to adequately disclose material information to its investors, leading to an inaccurate portrayal of the company's financial health and future prospects. The lawsuit aims to hold the company accountable for these alleged misrepresentations.

To be a member of the class action, investors do not need to take any immediate action. They can either retain their own legal counsel or remain as an absent member of the class action.